SCHEMBL859959

SCHEMBL859959

CCn1ccc(CO)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20464448 0.85 ALDH1A1 (0.37)
Hydrochloric Acid SCHEMBL6231685 0.82 ALDH1A1 (0.40)
SCHEMBL21945129 0.80 KCNH2 (0.37)
SCHEMBL4324417 0.80
SCHEMBL24618609 0.77 KCNH2 (0.38)
SCHEMBL18644049 0.77 RAB9A (0.36)
SCHEMBL10154714 0.77 KCNH2 (0.38)
SCHEMBL22912519 0.77 ALDH1A1 (0.37)
SCHEMBL294058 0.77 KCNH2 (0.35)
SCHEMBL16373730 0.77 RAB9A (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1413286-A1 Dyeing composition comprising at least one heterocyclic oxidation base and at least one substituted 2,3-diaminopyridine as a coupling agent L'OREAL (FR) 2004-04-28 EP claimed
EP-4739694-A2 MACROCYCLIC COMPOUNDS AND USE AS TYK2 INHIBITORS Blossomhill Therapeutics, Inc. (US) 2026-05-13 EP disclosed
WO-2025010294-A2 MACROCYCLIC COMPOUNDS AND USE AS TYK2 INHIBITORS BLOSSOMHILL THERAPEUTICS, INC. (US) 2025-01-09 WO disclosed
CN-117915919-A Polymorphs, pharmaceutical compositions and uses of azaaromatic ring compounds and pharmaceutically acceptable salts thereof 上海海雁医药科技有限公司 2024-04-19 CN disclosed
US-20230145793-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-05-11 US disclosed
US-20230145793-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-05-11 US disclosed
EP-4122927-A1 SUBSTITUTED PYRIMIDINE OR PYRIDINE AMINE DERIVATIVE, COMPOSITION THEREOF, AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (CN) 2023-01-25 EP disclosed
US-20220220117-A1 9-SUBSTITUTED AMINO TRIAZOLO QUINAZOLINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2022-07-14 US disclosed
US-11312719-B2 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use MERCK SHARP & DOHME CORP. (US) 2022-04-26 US disclosed
US-20210355104-A1 ADENOSINE RECEPTOR BINDING COMPOUNDS NIKANG THERAPEUTICS, INC. (US) 2021-11-18 US disclosed
EP-0998258-A1 OXIDATION DYEING COMPOSITION FOR KERATIN FIBRES L'OREAL (FR) 2000-05-10 EP disclosed
EP-0998257-A1 OXIDISING COMPOSITION AND USES FOR TREATING KERATIN FIBRES L'OREAL (FR) 2000-05-10 EP disclosed
EP-0975317-A1 OXIDISING COMPOSITION AND USE FOR DYEING, PERMANENTLY SETTING OR BLEACHING KERATIN FIBRES L'OREAL (FR) 2000-02-02 EP disclosed
EP-0975318-A1 OXIDISING COMPOSITION AND USES FOR DYEING, PERMANENTLY SETTING OR BLEACHING KERATIN FIBRES L'OREAL (FR) 2000-02-02 EP disclosed
EP-0966247-A1 OXIDISING COMPOSITION AND USES FOR DYEING, PERMANENTLY SETTING OR BLEACHING KERATIN FIBRES L'OREAL (FR) 1999-12-29 EP disclosed
WO-1999017721-A1 OXIDISING COMPOSITION AND USES FOR DYEING, PERMANENTLY SETTING OR BLEACHING KERATIN FIBRES L'OREAL (FR) 1999-04-15 WO disclosed
WO-1999017723-A1 OXIDISING COMPOSITION AND USE FOR DYEING, PERMANENTLY SETTING OR BLEACHING KERATIN FIBRES L'OREAL (FR) 1999-04-15 WO disclosed
WO-1999017728-A1 OXIDATION DYEING COMPOSITION FOR KERATIN FIBRES L'OREAL (FR) 1999-04-15 WO disclosed
WO-1999017727-A1 OXIDISING COMPOSITION AND USES FOR DYEING, PERMANENTLY SETTING OR BLEACHING KERATIN FIBRES L'OREAL (FR) 1999-04-15 WO disclosed
WO-1999017724-A1 OXIDISING COMPOSITION AND USES FOR TREATING KERATIN FIBRES L'OREAL (FR) 1999-04-15 WO disclosed